PLoS ONE 2011-01-01

The glycan shield of HIV is predominantly oligomannose independently of production system or viral clade.

Camille Bonomelli, Katie J Doores, D Cameron Dunlop, Victoria Thaney, Raymond A Dwek, Dennis R Burton, Max Crispin, Christopher N Scanlan

Index: PLoS ONE 6 , e23521, (2011)

Full Text: HTML

Abstract

The N-linked oligomannose glycans of HIV gp120 are a target for both microbicide and vaccine design. The extent of cross-clade conservation of HIV oligomannose glycans is therefore a critical consideration for the development of HIV prophylaxes. We measured the oligomannose content of virion-associated gp120 from primary virus from PBMCs for a range of viral isolates and showed cross-clade elevation (62-79%) of these glycans relative to recombinant, monomeric gp120 (∼30%). We also confirmed that pseudoviral production systems can give rise to notably elevated gp120 oligomannose levels (∼98%), compared to gp120 derived from a single-plasmid viral system using the HIV(LAI) backbone (56%). This study highlights differences in glycosylation between virion-associated and recombinant gp120.

Related Compounds

  • nafion

Related Articles:

Conversion of polar and non-polar algae oil lipids to fatty acid methyl esters with solid acid catalysts--A model compound study.

2015-09-01

[Bioresour. Technol. 191 , 300-5, (2015)]

Flexible Lamination Encapsulation.

2015-08-05

[Adv. Mater. 27 , 4308-14, (2015)]

Development of a low-cost optical sensor for cupric reducing antioxidant capacity measurement of food extracts.

2010-05-15

[Anal. Chem. 82(10) , 4252-8, (2010)]

[J. Electrochem. Soc. 140 , L55-57, (1993)]

Pt-Ir-IrO2NT thin-wall electrocatalysts derived from IrO2 nanotubes and their catalytic activities in methanol oxidation Shan CC, et al.

[Chem. Mater. 19(3) , 424-431., (2007)]

More Articles...